This report offers a detailed picture of the sleep aids market.
This report highlights the current and future market potential for sleep aids and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as key market players.
This report details market shares for sleep aids based on product, sleep disorder and geography. Based on product, the market is segmented into mattresses and pillows, sleep apnea devices, medications, sleep laboratories, and home sleep tests. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS) and others.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2021 through 2027. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Report Includes
- 33 data tables and 37 additional tables
- A comprehensive overview and an up-to-date analysis of the global market for sleep aids
- Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023 and 2025, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for sleep aids, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for global sleep aids market in USD million values, and corresponding market share analysis based on product type, sleep disorder type, and region
- Updated information on market drivers and opportunities for sleep aids industry, key shifts and regulations, technology specific challenges, and other demographic factors affecting the sleep aids market demand over the forecast period (2022-2027)
- Country specific data and market value analysis for the U.S., Canada, Germany, U.K., France, Italy, Spain, Australia, Japan, China, India, South Korea, and other emerging countries
- A comparative study and Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the sleep aids market
- Holistic review of the impact of the COVID-19 pandemic and the Russia-Ukraine war on the global market for sleep aids
- Coverage of the technological, economic, and business considerations of the sleep aids market, with global market data analyses and growth forecasts through 2027
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
- Detailed company profiles of the leading market players, including Advanced Brain Monitoring Inc., Ambulatory Monitoring Inc. (AMI), Boehringer Ingelheim GmbH, Fisher & Paykel Healthcare Ltd., Pfizer Inc., and ResMed Inc.
Table of Contents
Chapter 1 Introduction
1.1 Introduction
1.2 Study Goals and Objectives
1.3 Reasons for Doing this Study
1.4 Scope of Report
1.5 What's New in this Update?
1.6 Information Sources
1.7 Research Methodology
1.8 Geographic Breakdown
1.9 Analyst's Credentials
1.10 Custom Research
1.11 Related Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
3.1 Overview
3.2 Necessity of Sleep
3.3 Role of Ai in Sleep Aids
3.4 Physiology of Normal Sleep
3.5 Nrem and Rem Sleep Cycles
3.6 Four Stages of Nrem Sleep
3.6.1 Stage 1 Sleep
3.6.2 Stage 2 Sleep
3.6.3 Stages 3 and 4 Sleep
3.6.4 Rem Sleep
3.7 Physiology During Sleep
3.8 Newly Recommended Sleep Durations
3.9 Mechanism of Action for Different Sleep Drugs
3.10 Precautions for Using Sleeping Pills
3.11 Treating Insomnia Without Prescription Drugs
3.11.1 OTC Sleeping Pills
3.11.2 OTC Natural Sleep Aids
3.12 Current Research Focused on Sleep
3.13 Nih Funding for Research on Sleep
3.14 Porter's Five Forces Analysis of the Market for Sleep Aids
3.14.1 Bargaining Power of Suppliers
3.14.2 Bargaining Power of Buyers
3.14.3 Threat of New Entrants
3.14.4 Threat of Substitutes
3.14.5 Degree of Competition
Chapter 4 Impact of Covid-19 and Russia-Ukraine War on the Market
4.1 Overview
4.2 Impact of Covid-19 on Sleep Aids
4.2.1 Stress
4.2.2 Anxiety and Depression
4.2.3 Social Isolation
4.3 Impact of Covid-19 on Sleep
4.4 Social Impact of Covid-19
4.5 Impact on Insurance Providers
4.6 Impact on Health Technology Assement
4.7 Impact of Covid-19 and Its Aftermath on the Market for Sleep Aids
4.8 Impact of Russia-Ukraine War on the Market for Sleep Aids
Chapter 5 Market Dynamics
5.1 Overview
5.2 Market Drivers
5.2.1 Growing Number of Insomnia Disorders
5.2.2 Increasing Prevalence of Obstructive Sleep Apnea (Osa)
5.2.3 Increasing Demand for Medication Including Herbal Medicines Due to Unhealthy Lifestyles
5.2.4 Increase in Geriatric Population Across the World
5.3 Market Restraints
5.3.1 Side Effects of Medication
5.4 Market Opportunities
5.4.1 Growing Number of Sleep Aid Product Innovations
5.4.2 Opportunities in the Emerging Nations
Chapter 6 Market Breakdown by Product Type
6.1 Overview
6.1.1 Mattresses and Pillows
6.1.2 Sleep Apnea Devices
6.1.3 Medications
6.1.4 Sleep Laboratories
6.1.5 Home Sleep Testing (Hst)
Chapter 7 Market Breakdown by Sleep Disorder
7.1 Overview
7.2 Classification of Sleep Disorders
7.3 Polysomnogram Tests
7.3.1 Disorders Diagnosed by Psg
7.3.2 Equipment Used for the Diagnosis of Psg
7.3.3 Results of a Psg
7.4 Multiple Sleep Latency Test
7.5 Maintenance of Wakefulness Test
7.6 Actigraphy Tests
7.7 Global Market for Sleep Aids, by Sleep Disorder
7.7.1 Insomnia
7.7.2 Sleep Apnea
7.7.3 Restless Legs Syndrome (Rls)
7.7.4 Others
Chapter 8 Market Breakdown by Region
8.1 Overview
8.2 North America
8.2.1 United States
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 United Kingdom
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Latin America
8.6 Middle East and Africa
Chapter 9 Competitive Landscape
9.1 Industry Scenario
9.1.1 Opportunity: Emerging Markets
Chapter 10 Company Profiles
- Actigraph LLC
- Advanced Brain Monitoring Inc.
- Ambulatory Monitoring Inc.
- Apnea Sciences Corp.
- Blairex Laboratories Inc.
- Boehringer Ingelheim International GmbH
- Braebon Medical Corp.
- Cadwell Laboratories Inc.
- Camntech Ltd.
- Circadiance LLC
- Cleveland Medical Devices Inc.
- Drive Devilbiss Healthcare
- Fisher & Paykel Healthcare Corp. Ltd.
- Glidewell
- Hans Rudolph Inc.
- Modern Dental Laboratory Usa
- Nihon Kohden America Inc.
- Pfizer Inc.
- Resmed Inc.
Chapter 11 Appendix: List of Acronyms
List of Tables
Summary Table: Global Market for Sleep Aids, by Region, Through 2027
Table 1: Amount of Sleep Humans Need
Table 2: Physiological Changes During NREM and REM Sleep
Table 3: Selected Sleep Drugs, Mechanism of Action, Duration of Effect and Dependence Risk
Table 4: NICHD-Funded Research on Sleep
Table 5: Porter’s Five Forces Analysis: Global Sleep Aids Market
Table 6: Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 7: Herbal Sleep Medicine
Table 8: Number and Distribution of Persons Aged 60 and Over, by Region, 2019 and 2050
Table 9: Recent Developments in Sleep Aids, 2021-2023
Table 10: Global Market for Sleep Aids, by Product Type, Through 2027
Table 11: Comparison of Selected Innerspring Mattresses
Table 12: Comparison of Selected Memory Foam Mattresses
Table 13: Comparison of Selected Air Mattresses
Table 14: Global Market for Mattresses and Pillows as Sleep Aids, by Region, Through 2027
Table 15: Global Market for Sleep Apnea Devices, by Region, Through 2027
Table 16: Examples of Benzodiazepines
Table 17: Pharmacokinetic Profiles of Common Benzodiazepines and their Approved Indications
Table 18: Examples of New Sleeping Pills
Table 19: Comparative Efficacies of Selected New Sleeping Pills
Table 20: Global Market for Medication as Sleep Aids, by Region, Through 2027
Table 21: Global Market for Sleep Laboratories, by Region, Through 2027
Table 22: Home Sleep Tests vs. Facility-Based Testing
Table 23: Global Market for Home Sleep Test Aids, by Region, Through 2027
Table 24: Global Market for Sleep Aids, by Sleep Disorder, Through 2027
Table 25: Mandatory Assessment of Chronic Insomnia
Table 26: Physicians’ Examinations for the Diagnosis of Chronic Insomnia
Table 27: Drugs for Insomnia, by Type
Table 28: Most Frequently Prescribed Insomnia Drugs
Table 29: Global Market for Sleep Aids for Insomnia, by Region, Through 2027
Table 30: Global Market for Sleep Aids for Sleep Apnea, by Region, Through 2027
Table 31: Half-Life and Dosage Range of Drugs Used for Restless Leg Syndrome
Table 32: Global Market for Sleep Aids for Restless Legs Syndrome, by Region, Through 2027
Table 33: Prescription Drugs Used for Narcolepsy
Table 34: Global Market for Sleep Aids for Other Sleep Disorders, by Region, Through 2027
Table 35: Global Market for Sleep Aids, by Region, Through 2027
Table 36: North American Market for Sleep Aids, by Product Type, Through 2027
Table 37: North American Market for Sleep Aids, by Sleep Disorder, Through 2027
Table 38: North American Market for Sleep Aids, by Country, Through 2027
Table 39: European Market for Sleep Aids, by Product Type, Through 2027
Table 40: European Market for Sleep Aids, by Sleep Disorder, Through 2027
Table 41: European Market for Sleep Aids, by Country, Through 2027
Table 42: Asia-Pacific Market for Sleep Aids, by Product Type, Through 2027
Table 43: Asia-Pacific Market for Sleep Aids, by Sleep Disorder, Through 2027
Table 44: Asia-Pacific Market for Sleep Aids, by Country, Through 2027
Table 45: Latin American Market for Sleep Aids, by Product Type, Through 2027
Table 46: Latin American Market for Sleep Aids, by Sleep Disorder, Through 2027
Table 47: Middle Eastern and African Market for Sleep Aids, by Product Type, Through 2027
Table 48: Middle Eastern and African Market for Sleep Aids, by Sleep Disorder, Through 2027
Table 49: ActiGraph LLC: Product Portfolio
Table 50: Advanced Brain Monitoring Inc.: Product Portfolio
Table 51: Ambulatory Monitoring Inc.: Product Portfolio
Table 52: Apnea Sciences: Product Portfolio
Table 53: Apnea Sciences: Recent Developments, 2018 and 2019
Table 54: Blairex Laboratories Inc.: Product Portfolio
Table 55: Boehringer Ingelheim International GmbH: Product Portfolio
Table 56: Braebon Medical Corp.: Product Portfolio
Table 57: Cadwell Industries Inc.: Product Portfolio
Table 58: CamNtech Ltd.: Product Portfolio
Table 59: Circadiance: Product Portfolio
Table 60: Cleveland Medical Devices Inc.: Product Portfolio
Table 61: Drive DeVilbiss Healthcare: Product Portfolio
Table 62: Fisher & Paykel Healthcare Ltd.: Product Portfolio
Table 63: Glidewell: Product Portfolio
Table 64: Hans Rudolph Inc.: Product Portfolio
Table 65: Modern Dental Laboratory USA: Product Portfolio
Table 66: Nihon Kohden Corp.: Product Portfolio
Table 67: Pfizer Inc.: Products and Services
Table 68: ResMed: Product Portfolio
Table 69: Major Acronyms Used in This Report
List of Figures
Summary Figure: Global Market Shares of Sleep Aids, by Region, 2021
Figure 1: Global Market Shares of Sleep Aids, by Product, 2021
Figure 2: Global Market Shares of Mattresses and Pillows in Sleep Aids, by Region, 2021
Figure 3: Global Market Shares of Sleep Apnea Devices, by Region, 2021
Figure 4: Global Market Shares of Medication in Sleep Aids, by Region, 2021
Figure 5: Global Market Shares of Sleep Laboratories, by Region, 2021
Figure 6: Global Market Shares of Home Sleep Test Aids, by Region, 2021
Figure 7: Global Market Shares of Sleep Aids, by Sleep Disorder, 2021
Figure 8: Global Market Shares of Sleep Aids for Insomnia, by Region, 2021
Figure 9: Global Market Shares of Sleep Aids for Sleep Apnea, by Region, 2021
Figure 10: Global Market Shares of Sleep Aids for Restless Legs Syndrome, by Region, 2021
Figure 11: Global Market Shares of Sleep Aids for Other Sleep Disorders, by Region, 2021
Figure 12: Global Market Shares of Sleep Aids, by Region, 2021
Figure 13: The U.S. Market for Sleep Aids, 2021-2027
Figure 14: Canadian Market for Sleep Aids, 2021-2027
Figure 15: German Market for Sleep Aids, 2021-2027
Figure 16: U.K. Market for Sleep Aids, 2021-2027
Figure 17: French Market for Sleep Aids, 2021-2027
Figure 18: Italian Market for Sleep Aids, 2021-2027
Figure 19: Spanish Market for Sleep Aids, 2021-2027
Figure 20: Rest of the European Market for Sleep Aids, 2021-2027
Figure 21: Chinese Market for Sleep Aids, 2021-2027
Figure 22: Japanese Market for Sleep Aids, 2021-2027
Figure 23: Indian Market for Sleep Aids, 2021-2027
Figure 24: Australian Market for Sleep Aids, 2021-2027
Figure 25: South Korean Market for Sleep Aids, 2021-2027
Figure 26: Rest of Asia-Pacific Market for Sleep Aids, 2021-2027
Figure 27: Boehringer Ingelheim International GmbH: Annual Revenue, 2019-2021
Figure 28: Boehringer Ingelheim International GmbH: Revenue Share, by Business Segment, 2021
Figure 29: Boehringer Ingelheim International GmbH: Revenue Share, by Region, 2021
Figure 30: Fisher & Paykel Healthcare Ltd.: Annual Revenue, 2020-2022
Figure 31: Fisher & Paykel Healthcare Ltd.: Revenue Share, by Product Group, 2022
Figure 32: Fisher & Paykel Healthcare Ltd.: Revenue Share, by Region, 2022
Figure 33: Pfizer Inc.: Annual Revenue, 2019-2021
Figure 34: Pfizer Inc.: Revenue Share, by Business Segment, 2021
Figure 35: Pfizer Inc.: Revenue Share, by Region, 2021
Figure 36: ResMed: Annual Revenue, 2020-2022
Figure 37: ResMed: Revenue Share, by Business Unit, 2022
Figure 38: ResMed: Revenue Share, by Region, 2022
Companies Mentioned
- Actigraph LLC
- Advanced Brain Monitoring Inc.
- Ambulatory Monitoring Inc.
- Apnea Sciences Corp.
- Blairex Laboratories Inc.
- Boehringer Ingelheim International GmbH
- Braebon Medical Corp.
- Cadwell Laboratories Inc.
- Camntech Ltd.
- Circadiance LLC
- Cleveland Medical Devices Inc.
- Drive Devilbiss Healthcare
- Fisher & Paykel Healthcare Corp. Ltd.
- Glidewell
- Hans Rudolph Inc.
- Modern Dental Laboratory Usa
- Nihon Kohden America Inc.
- Pfizer Inc.
- Resmed Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 152 |
| Published | February 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 89.6 Billion |
| Forecasted Market Value ( USD | $ 125.3 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
